OncoCyte Corp (OCX) PT Lowered to $0.45 at Needham & Company
Get Alerts OCX Hot Sheet
Price: $3.20 --0%
Rating Summary:
4 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 9
Rating Summary:
4 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 9
Join SI Premium – FREE
Needham & Company analyst Mike Matson lowered the price target on OncoCyte Corp (NASDAQ: OCX) to $0.45 (from $1.40) while maintaining a Buy rating.
You May Also Be Interested In
- Packaging Corp. of America (PKG) PT Raised to $292 at UBS Following Containerboard Price Increase
- Advance Auto Parts (AAP) PT Raised to $67 at RBC Capital
- MongoDB (MDB) PT Raised at RBC Capital; 'Shares represent an attractive buying opportunity'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share